These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 2568836)
1. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol. Ishibashi T; Mitomi A; Tatebe S; Imai S Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836 [TBL] [Abstract][Full Text] [Related]
2. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696 [TBL] [Abstract][Full Text] [Related]
3. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats. Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent. Uchida W; Shibasaki K; Asano M; Takenaka T Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704 [TBL] [Abstract][Full Text] [Related]
6. Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol. Ishibashi T; Ohta H; Jin H; Mitomi A; Tatebe S; Nakazawa M; Imai S Arzneimittelforschung; 1989 Oct; 39(10):1225-8. PubMed ID: 2575385 [TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs. Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog. Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764 [TBL] [Abstract][Full Text] [Related]
9. Hypotensive effect of bopindolol in pithed rats. Tanaka H; Takahashi S; Shigenobu K Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742 [TBL] [Abstract][Full Text] [Related]
10. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs. Abiko Y; Gotoh H; Yokoyama T; Abiko T; Hashizume H; Akiyama K Arch Int Pharmacodyn Ther; 1994; 327(1):40-55. PubMed ID: 7944827 [TBL] [Abstract][Full Text] [Related]
11. [Beta-blocking actions and the partial agonist activity of bopindolol, a new beta-adrenoceptor antagonist, and its two metabolites]. Chin WP; Sun HT; Kawada T; Imai S Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):27-33. PubMed ID: 2571551 [TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)]. Matsunaga K; Ueda M Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655 [TBL] [Abstract][Full Text] [Related]
13. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol. Boneli J Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363 [No Abstract] [Full Text] [Related]
15. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs. Himori N; Ishimori T; Izumi A; Hiramatsu Y Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Aellig WH Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol. Magometschnigg D; Bonelli J; Kaik G Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol]. Gries J; Unger L; Einig H; Friedrich L; Hofmann HP; Kreiskott H; Lehmann HD; von Philipsborn G; Wuppermann D; Zimmermann F Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243 [TBL] [Abstract][Full Text] [Related]
19. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients. Kirch W; Axthelm T Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312 [TBL] [Abstract][Full Text] [Related]